NCT00839072View on ClinicalTrials.gov

Comparative Bioavailability Study of Extended-release and Immediate-release Trazodone in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

February 28, 2009

Study Completion Date

March 31, 2009

Conditions
Healthy
Interventions
DRUG

Trazodone HCl

100 mg immediate-release tablet, dosing q8h

DRUG

Trazodone HCl

300 mg extended-release caplet, single dose

Trial Locations (1)

H7V 4B3

Algorithme Pharma Inc., Laval

Sponsors

Lead Sponsor

Labopharm Inc.

Collaborators (1)

Algorithme Pharma Inc
All Listed Sponsors
collaborator

Algorithme Pharma Inc

INDUSTRY

lead

Labopharm Inc.

INDUSTRY

NCT00839072 - Comparative Bioavailability Study of Extended-release and Immediate-release Trazodone in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter